Drug:
Reaction: DRUG INTERACTION
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26499582 |
EU |
||
Cardiac arrest, Cardiopulmonary failure, Toxicity to various agents, Seizure, Fall, Overdose, Drug abuse, Drug interaction, Drug interaction, Potentiating drug interaction, |
||||
NICOTINE, NICOTINE POLACRILEX, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 302 | 26499658 |
EU |
||
Paradoxical drug reaction, Drug interaction, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, ASCORBIC ACID, FOLIC ACID, GABAPENTIN, MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, THIAMINE HYDROCHLORIDE, |
||||
| 303 | 26499661 |
EU |
51 | 1 |
Seizure, Drug interaction, Off label use, |
||||
VALPROIC ACID, ERTAPENEM, ERTAPENEM SODIUM, FLUCONAZOLE, BACLOFEN, GABAPENTIN, SACCHAROMYCES CEREVISIAE, ENOXAPARIN SODIUM, |
||||
| 304 | 26499767 |
EU |
2 | |
Drug interaction, Hepatotoxicity, Liver injury, Off label use, |
||||
CYCLOSPORINE, CYCLOSPORINE, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, ANTI-THYMOCYTE GLOBULIN (RABBIT), ANTI-THYMOCYTE GLOBULIN (RABBIT), ACYCLOVIR, |
||||
| 305 | 26499768 |
US |
49 | 1 |
Oculogyric crisis, Drug interaction, Drug effective for unapproved indication, |
||||
AMANTADINE, SUGAMMADEX, LORAZEPAM, LORAZEPAM, DEXMEDETOMIDINE, ROCURONIUM, ROCURONIUM BROMIDE, |
||||
| 306 | 26499771 |
IN |
25 | 2 |
Peripheral vascular disorder, Ergot poisoning, Drug interaction, |
||||
SUMATRIPTAN, SUMATRIPTAN SUCCINATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 307 | 26499848 |
US |
62 | 2 |
Toxicity to various agents, Drug interaction, Lactic acidosis, Shock, Metabolic acidosis, Acute kidney injury, Liver injury, Atrial fibrillation, Acute hepatic failure, Multiple organ dysfunction syndrome, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GLIPIZIDE, GLIPIZIDE-TABLETS, GLIPIZIDE, GLIPIZIDE-TABLETS, GLIPIZIDE, GLIPIZIDE-TABLETS, GLIPIZIDE, GLIPIZIDE-TABLETS, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, HYDROXYZINE, HYDROXYZINE, HYDROXYZINE, HYDROXYZINE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, |
||||
| 308 | 26500007 |
US |
62 | 1 |
Encephalopathy, Drug interaction, Product use in unapproved indication, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, CEFTRIAXONE, CEFTRIAXONE SODIUM, DAPTOMYCIN, MICAFUNGIN, MICAFUNGIN SODIUM, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
| 309 | 26500113 |
EU |
59 | 1 |
Drug interaction, Immunosuppressant drug level increased, |
||||
VORICONAZOLE, VORICONAZOLE, CYCLOSPORINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 310 | 26500747 |
EU |
51 | 2 |
Persistent genital arousal disorder, Drug interaction, Product use in unapproved indication, |
||||
PREGABALIN, PREGABALIN, MEDROXYPROGESTERONE ACETATE, ESTRIOL0.2%, ESTRIOL, TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, |
||||
| 311 | 26501128 |
EU |
51 | 2 |
Persistent genital arousal disorder, Drug interaction, Product use in unapproved indication, |
||||
TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, MEDROXYPROGESTERONE ACETATE, ESTRIOL0.2%, ESTRIOL, PREGABALIN, PREGABALIN, |
||||
| 312 | 26501129 |
US |
87 | 1 |
Pneumatosis intestinalis, Intestinal ischaemia, Drug interaction, Product use in unapproved indication, |
||||
PREDNISONE, PREDNISONE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, ABIRATERONE ACETATE, ABIRATERONE, GLIPIZIDE, GLIPIZIDE-TABLETS, |
||||
| 313 | 26501172 |
US |
87 | 1 |
Pneumatosis intestinalis, Drug interaction, |
||||
PREDNISONE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, ABIRATERONE ACETATE, ABIRATERONE, |
||||
| 314 | 26501212 |
63 | 2 | |
Liver function test increased, Platelet count increased, Therapy interrupted, Drug interaction, |
||||
PAZOPANIB, PAZOPANIB HYDROCHLORIDE, PANTOPRAZOLE, |
||||
| 315 | 26501242 |
EU |
68 | 1 |
Dizziness exertional, Malaise, Fall, Hiccups, Night sweats, Oedema peripheral, Nocturia, Dysphagia, Cough, Hypotension, Drug interaction, |
||||
BISOPROLOL FUMARATE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, TELMISARTAN, DOXAZOSIN, DOXAZOSIN MESYLATE, FUROSEMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, TIOTROPIUM BROMIDE, BECLOMETHASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, APIXABAN, |
||||
| 316 | 26501251 |
EU |
38 | 2 |
Agranulocytosis, Drug interaction, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PIROXICAM, PIROXICAM, PIROXICAM, PIROXICAM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, |
||||
| 317 | 26501388 |
US |
57 | |
Hypercholesterolaemia, Hypertriglyceridaemia, Drug interaction, |
||||
BELUMOSUDIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LIOTHYRONINE SODIUM, DESONIDE, FENOFIBRATE, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, FLUCONAZOLE, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, FOLIC ACID, SUMATRIPTAN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, CARBOXYMETHYLCELLULOSE SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, URSODIOL, URSOSIOL, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, ERGOCALCIFEROL, |
||||
| 318 | 26501450 |
EU |
2 | |
Death, Insomnia, Somnolence, Weight increased, Oedema peripheral, Drug interaction, |
||||
PREGABALIN, OXYCODONE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, FUROSEMIDE, MORPHINE, TOPIRAMATE, TOPIRAMATE SPINKLE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, GABAPENTIN, GABAPENTIN, |
||||
| 319 | 26501796 |
EU |
51 | 2 |
Persistent genital arousal disorder, Product use in unapproved indication, Drug interaction, |
||||
PREGABALIN, MEDROXYPROGESTERONE ACETATE, ESTRIOL0.2%, ESTRIOL, |
||||
| 320 | 26502066 |
EU |
51 | 2 |
Persistent genital arousal disorder, Product use in unapproved indication, Drug interaction, |
||||
PREGABALIN, MEDROXYPROGESTERONE ACETATE, ESTRIOL0.2%, ESTRIOL, |
||||
| 321 | 26502094 |
EU |
51 | 2 |
Persistent genital arousal disorder, Product use in unapproved indication, Drug interaction, |
||||
PREGABALIN, MEDROXYPROGESTERONE ACETATE, ESTRIOL0.2%, ESTRIOL, |
||||
| 322 | 26502103 |
EU |
51 | 2 |
Persistent genital arousal disorder, Product use in unapproved indication, Drug interaction, |
||||
PREGABALIN, MEDROXYPROGESTERONE ACETATE, ESTRIOL0.2%, ESTRIOL, |
||||
| 323 | 26502509 |
US |
2 | |
Impaired healing, Drug interaction, |
||||
COLLAGENASE SANTYL, COLLAGENASE SANTYL, IODINE, |
||||
| 324 | 26502600 |
EU |
87 | 1 |
Gastrointestinal haemorrhage, Shock, Drug interaction, |
||||
RIVAROXABAN, |
||||
| 325 | 26506404 |
15 | 2 | |
Anxiety, Panic attack, Suicidal ideation, Hallucinations, mixed, Emotional distress, Behaviour disorder, Depression, School refusal, Drug interaction, Therapy change, Substance use, Self-medication, |
||||
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ESCITALOPRAM, ESCITALOPRAM, SERTRALINE HYDROCHLORIDE, CLONIDINE, |
||||
| 326 | 26497495 |
US |
32 | 2 |
Cholestatic liver injury, Hypothyroidism, Wrong technique in product usage process, Therapeutic response decreased, Drug interaction, |
||||
CHOLESTYRAMINE, CHOLESTYRAMINE, PANTOPRAZOLE, DAPAGLIFLOZIN, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, TIRZEPATIDE, |
||||
| 327 | 26497585 |
GB |
78 | 1 |
Deep vein thrombosis, Drug interaction, |
||||
APIXABAN, PRIMIDONE, |
||||
| 328 | 26497588 |
GB |
65 | 2 |
Drug interaction, Hypertension, |
||||
LOSARTAN, AMLODIPINE, CARBAMAZEPINE, ATENOLOL, DOXAZOSIN, DOXAZOSIN MESYLATE, SPIRONOLACTONE, |
||||
| 329 | 26499736 |
65 | 1 | |
Chest pain, Seizure, Drug interaction, CYP1A2 gene status assay, |
||||
| 330 | 26499829 |
48 | 2 | |
Drug interaction, Toxicity to various agents, Migraine with aura, Seizure, Therapy cessation, Loss of consciousness, Potentiating drug interaction, |
||||
TIRZEPATIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, LAMOTRIGINE, OXYCODONE, VALACYCLOVIR HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ROSUVASTATIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, OLANZAPINE, LEVOTHYROXINE SODIUM, PRIMIDONE, PROGESTERONE, OXYCODONE, |
||||
| 331 | 26497156 |
EU |
54 | 2 |
Venous thrombosis, Drug interaction, Disseminated tuberculosis, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, RIFAMPIN, |
||||
| 332 | 26497210 |
GB |
||
Drug interaction, Deep vein thrombosis, |
||||
APIXABAN, PRIMIDONE, |
||||
| 333 | 26497263 |
GB |
60 | 2 |
Drug interaction, Clonic convulsion, Contraindicated product prescribed, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, FOLIC ACID, IRON, |
||||
| 334 | 26497264 |
IN |
41 | 1 |
Delirium, Drug interaction, |
||||
CLONAZEPAM, OLANZAPINE, OLANZAPINE, VALPROATE SODIUM, VALPROATE SODIUM, |
||||
| 335 | 26497313 |
EU |
80 | 1 |
Acute kidney injury, Drug interaction, |
||||
METHOTREXATE, METHOTREXATE SODIUM, ZOLEDRONIC ACID, |
||||
| 336 | 26492049 |
AU |
78 | 2 |
Hyperkalaemia, Dehydration, Acute kidney injury, Lactic acidosis, Hypoglycaemia, Drug interaction, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SEMAGLUTIDE, |
||||
| 337 | 26492099 |
EU |
12 | 2 |
Neuroleptic malignant syndrome, Serotonin syndrome, Drug interaction, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, |
||||
| 338 | 26492218 |
EU |
70 | 1 |
Vaccination failure, Drug interaction, Herpes zoster, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, EVEROLIMUS, EVEROLIMUS TABLETS, PREDNISONE, FOLIC ACID, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, FUROSEMIDE, LANSOPRAZOLE, MOMETASONE, |
||||
| 339 | 26492236 |
70 | 2 | |
Rhabdomyolysis, Acute kidney injury, Hepatic function abnormal, Neurotoxicity, Drug interaction, |
||||
KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, CYCLOSPORINE, SIMVASTATIN, |
||||
| 340 | 26492534 |
US |
85 | 2 |
Chest pain, Melaena, Gait disturbance, Nausea, Haemoglobin decreased, Drug interaction, Asthenia, Therapy interrupted, |
||||
BRENSOCATIB, BRENSOCATIB, ATENOLOL, AZELASTINE, FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PRAZOSIN, RANOLAZINE, LEVOTHYROXINE SODIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TICAGRELOR, |
||||
| 341 | 26492698 |
US |
70 | 2 |
Lactic acidosis, Drug interaction, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LINEZOLID, APIXABAN, |
||||
| 342 | 26492798 |
EU |
70 | 1 |
Herpes zoster, Vaccination failure, Drug interaction, |
||||
PREDNISONE, EVEROLIMUS, EVEROLIMUS TABLETS, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, FOLIC ACID, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, FUROSEMIDE, LANSOPRAZOLE, MOMETASONE FUROATE, MOMETASONE, |
||||
| 343 | 26493532 |
US |
||
Cholestatic liver injury, Hypothyroidism, Wrong technique in product usage process, Therapeutic response decreased, Drug interaction, |
||||
CHOLESTYRAMINE, CHOLESTYRAMINE, PANTOPRAZOLE, DAPAGLIFLOZIN, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, TIRZEPATIDE, |
||||
| 344 | 26493793 |
TR |
11 | 2 |
Chorea, Drug interaction, Paradoxical drug reaction, Insomnia, Screaming, Hallucination, Agitation, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, PROPOFOL, FENTANYL, ROCURONIUM, ROCURONIUM BROMIDE, CEFAZOLIN SODIUM, CEFAZOLIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SUGAMMADEX, |
||||
| 345 | 26493834 |
EU |
57 | 1 |
Therapeutic product effect incomplete, Neuromuscular blockade, Drug interaction, |
||||
DONEPEZIL HYDROCHLORIDE, ROCURONIUM, ROCURONIUM BROMIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, MIRTAZAPINE, ROSUVASTATIN, DENOSUMAB, PROPOFOL, FENTANYL, OXYGEN, 0XYGEN, |
||||
| 346 | 26494024 |
84 | 1 | |
Drug interaction, Haemoglobin decreased, |
||||
ERYTHROMYCIN, |
||||
| 347 | 26494061 |
GB |
65 | 2 |
Hypertension, Drug interaction, |
||||
LOSARTAN, CARBAMAZEPINE, AMLODIPINE, ATENOLOL, SPIRONOLACTONE, DOXAZOSIN, DOXAZOSIN MESYLATE, |
||||
| 348 | 26494111 |
IN |
||
Delirium, Drug interaction, |
||||
OLANZAPINE, OLANZAPINE, VALPROIC ACID, VALPROIC ACID, CLONAZEPAM, |
||||
| 349 | 26494185 |
EU |
81 | 1 |
Lactic acidosis, Drug level above therapeutic, Drug interaction, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, KETOPROFEN, TRANDOLAPRIL, TRANDOLAPRIL TABLETS, |
||||
| 350 | 26494258 |
CA |
1 | |
Depression, Drug interaction, |
||||
BUPROPION, LAMIVUDINE, LAMIVUDINE ORAL, ATAZANAVIR SULFATE, ATAZANAVIR, CLONAZEPAM, EFAVIRENZ, LOPINAVIR AND RITONAVIR, QUETIAPINE FUMARATE, QUETIAPINE, SERTRALINE HYDROCHLORIDE, VALPROIC ACID, |
||||
| 351 | 26494259 |
CA |
1 | |
Depression, Drug interaction, |
||||
LAMIVUDINE, LAMIVUDINE ORAL, BUPROPION, ATAZANAVIR SULFATE, ATAZANAVIR, CLONAZEPAM, EFAVIRENZ, LOPINAVIR AND RITONAVIR, QUETIAPINE FUMARATE, QUETIAPINE, SERTRALINE HYDROCHLORIDE, VALPROIC ACID, |
||||
| 352 | 26494336 |
PR |
41 | 2 |
Adrenal insufficiency, Cushing^s syndrome, Drug interaction, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, AMLODIPINE, |
||||
| 353 | 26494409 |
EU |
72 | 2 |
Serotonin syndrome, Drug interaction, |
||||
QUETIAPINE, QUETIAPINE, SERTRALINE, FLUCONAZOLE, LINEZOLID, MEROPENEM, |
||||
| 354 | 26494413 |
14 | ||
Suicide attempt, Hypoglycaemia, Intentional overdose, Drug interaction, |
||||
INSULIN ASPART, INSULIN DEGLUDEC, |
||||
| 355 | 26494430 |
EU |
2 | |
Drug interaction, Hepatotoxicity, Liver injury, Product prescribing issue, |
||||
POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, CYCLOSPORINE, CYCLOSPORINE, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, ANTI-THYMOCYTE GLOBULIN (RABBIT), ANTI-THYMOCYTE GLOBULIN (RABBIT), ACYCLOVIR, |
||||
| 356 | 26494925 |
65 | 2 | |
Hypertension, Drug interaction, |
||||
LOSARTAN, CARBAMAZEPINE, AMLODIPINE, ATENOLOL, SPIRONOLACTONE, DOXAZOSIN, DOXAZOSIN MESYLATE, |
||||
| 357 | 26495013 |
US |
28 | 1 |
Drug interaction, Disease progression, Therapeutic response decreased, Vomiting, |
||||
FLUCONAZOLE, COLCHICINE, AMPHOTERICIN B, |
||||
| 358 | 26495818 |
40 | ||
Cardiac failure, Respiratory failure, Pulmonary congestion, Respiratory depression, Seizure, Toxicity to various agents, Drug interaction, Cardiac arrest, Oedema, Cerebral congestion, Arteriosclerosis, Hepatic steatosis, Peripheral venous disease, |
||||
| 359 | 26495820 |
30 | ||
Brain oedema, Brain death, Drug interaction, Arrhythmia, Serotonin syndrome, Cardiac arrest, Hyponatraemia, Ventricular hypokinesia, Hypokalaemia, Metabolic acidosis, Nervous system disorder, Fall, Hyponatraemia, Hypochloraemia, Tremor, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, CHLORPHENIRAMINE MALEATE, |
||||
| 360 | 26495837 |
GB |
65 | 2 |
Hypertension, Drug interaction, |
||||
AMLODIPINE, CARBAMAZEPINE, ATENOLOL, DOXAZOSIN, DOXAZOSIN MESYLATE, LOSARTAN, OXCARBAZEPINE, SPIRONOLACTONE, |
||||
| 361 | 26495972 |
EU |
75 | 2 |
Pulmonary embolism, Drug interaction, |
||||
RIVAROXABAN, PRIMIDONE, |
||||
| 362 | 26496056 |
EU |
1 | |
Drug interaction, Therapeutic agent-diagnostic test interaction, Nephropathy toxic, Drug ineffective, Exposure to radiation, Bone scan abnormal, |
||||
CISPLATIN, |
||||
| 363 | 26496071 |
EU |
70 | 1 |
Herpes zoster, Drug interaction, Vaccination failure, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, EVEROLIMUS, EVEROLIMUS TABLETS, PREDNISONE, FOLIC ACID, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, FUROSEMIDE, LANSOPRAZOLE, MOMETASONE FUROATE, MOMETASONE, |
||||
| 364 | 26496108 |
53 | 2 | |
Depression suicidal, Drug interaction, Restlessness, Food aversion, Anxiety, Sleep disorder, Nausea, |
||||
TIRZEPATIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 365 | 26496265 |
EU |
61 | |
Ascites, Cardio-respiratory arrest, Decreased appetite, Tinnitus, Chills, Amaurosis fugax, Diplopia, Pruritus, Somnolence, Vision blurred, Coma, Sepsis, Generalised oedema, Blood pressure increased, Fatigue, Urinary tract disorder, Diarrhoea, Headache, Cough, Photophobia, Dizziness, Eye pain, Drug interaction, Haemorrhagic stroke, |
||||
IMATINIB, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, FLUVASTATIN, FLUVASTATIN SODIUM, FLUVASTATIN, BISOPROLOL FUMARATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, PROPRANOLOL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE, NILOTINIB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, EZETIMIBE, ETANERCEPT, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, BRINZOLAMIDE, BRINZOLAMIDE, BRINZOLAMIDE, IMATINIB MESYLATE, IMATINIB, RIBAVIRIN, ALISKIREN, ALISKIREN HEMIFUMARATE, ALISKIREN, ALISKIREN HEMIFUMARATE, ALISKIREN, ALISKIREN HEMIFUMARATE, ALISKIREN, ALISKIREN HEMIFUMARATE, ALISKIREN, ALISKIREN HEMIFUMARATE, ALISKIREN, ALISKIREN HEMIFUMARATE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PITAVASTATIN CALCIUM, PITAVASTATIN, PITAVASTATIN CALCIUM, PITAVASTATIN, PITAVASTATIN CALCIUM, PITAVASTATIN, PITAVASTATIN CALCIUM, PITAVASTATIN, PITAVASTATIN CALCIUM, PITAVASTATIN, PITAVASTATIN CALCIUM, PITAVASTATIN, VORTIOXETINE, VORTIOXETINE, VORTIOXETINE, VORTIOXETINE, VORTIOXETINE, INDOMETHACIN, INDOMETHACIN, INDOMETHACIN, INDOMETHACIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DUTASTERIDE, DUTASTERIDE, DUTASTERIDE, DUTASTERIDE, DUTASTERIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, POTASSIUM IODIDE, POTASSIUM IODIDE, POTASSIUM IODIDE, POTASSIUM IODIDE, POTASSIUM IODIDE, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, INDOMETHACIN, INDOMETHACIN, ANASTROZOLE, ANASTROZOLE TABLETS, PENTOXIFYLLINE, PENTOXIFYLLINE, PENTOXIFYLLINE, PENTOXIFYLLINE, PENTOXIFYLLINE, PENTOXIFYLLINE, PENTOXIFYLLINE, FENOFIBRATE, FENOFIBRATE, FENOFIBRATE, FENOFIBRATE, FENOFIBRATE, DONEPEZIL HYDROCHLORIDE, PRAVASTATIN SODIUM, DUTASTERIDE, TAMSULOSIN HYDROCHLORIDE, |
||||
| 366 | 26496406 |
EU |
60 | 1 |
Cardiac disorder, Diabetes mellitus, Diabetic metabolic decompensation, Listless, Disturbance in attention, Drug interaction, Pain in extremity, Hepatic steatosis, Iron deficiency, Diabetic retinopathy, Prostatic specific antigen increased, Carotid arteriosclerosis, Peripheral arterial occlusive disease, Peripheral arterial occlusive disease, |
||||
VALSARTAN, VALSARTAN ORAL, AMLODIPINE, BISOPROLOL FUMARATE, SIMVASTATIN, SIMVASTATIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EZETIMIBE, EMPAGLIFLOZIN, EMPAGLIFLOZIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, INSULIN DEGLUDEC, LIRAGLUTIDE, HYDROCHLOROTHIAZIDE, ROSUVASTATIN, INSULIN GLARGINE, ERGOCALCIFEROL, PRASUGREL, |
||||
| 367 | 26485342 |
US |
||
Arrhythmia, Heart rate irregular, Dizziness, Malaise, Chills, Diarrhoea, Off label use, Drug interaction, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, APIXABAN, METHOCARBAMOL, METHOCARBAMOL TABLETS, ERGOCALCIFEROL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 368 | 26485439 |
US |
||
Central vision loss, Vitreous opacities, Visual acuity reduced transiently, Drug interaction, |
||||
PEGCETACOPLAN, PEGCETACOPLAN, FARICIMAB, FARICIMAB, |
||||
| 369 | 26485573 |
US |
2 | |
Drug interaction, Product use in unapproved indication, |
||||
RIFAMPIN, ETHAMBUTOL HYDROCHLORIDE, CLARITHROMYCIN, |
||||
| 370 | 26485798 |
GB |
2 | |
Melaena, Haemoptysis, Drug interaction, |
||||
RIVAROXABAN, SEMAGLUTIDE, RIVAROXABAN, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 371 | 26486358 |
EU |
76 | 1 |
Acute kidney injury, Hyperhidrosis, Pallor, Dyspnoea, Palpitations, Vomiting, Emotional distress, Blood bicarbonate decreased, Fatigue, Blood lactic acid increased, Metabolic acidosis, Feeling abnormal, Acidosis, Hypotension, Lactic acidosis, Renal impairment, Drug interaction, Abdominal pain upper, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN GLARGINE, CANAGLIFLOZIN, CANAGLIFLOZIN, |
||||
| 372 | 26486433 |
EU |
63 | 2 |
Hyperaesthesia, Allodynia, Neuralgia, Drug interaction, Product adhesion issue, Product quality issue, Skin exfoliation, Application site pain, Application site pain, Application site pain, Application site warmth, Application site warmth, |
||||
CAPSAICIN, CAPSAICIN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, GABAPENTIN, |
||||
| 373 | 26486526 |
TR |
3 | 1 |
Treatment noncompliance, Mania, Toxicity to various agents, Cerebral atrophy, Neuroleptic malignant syndrome, Drug interaction, |
||||
MODAFINIL, SERTRALINE, BUPROPION, QUETIAPINE, QUETIAPINE, CLONAZEPAM, AMANTADINE, AMANTADINE, OLANZAPINE, AMISULPRIDE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 374 | 26486817 |
EU |
1 | |
Hypertension, Drug interaction, Arrhythmia, |
||||
CANDESARTAN CILEXETIL, CARVEDILOL, DORZOLAMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 375 | 26486905 |
EU |
62 | 1 |
Drug interaction, Urinary retention, Somnolence, Wrong patient received product, |
||||
OLANZAPINE, QUETIAPINE, OXAZEPAM, VALPROATE SODIUM, CLOBAZAM, ATROPINE SULFATE, ATROPINE, |
||||
| 376 | 26487470 |
EU |
86 | 2 |
Delirium, Oxygen saturation decreased, Urinary retention, Listless, Hyponatraemia, Liver function test increased, Atrial fibrillation, Apathy, Hypokalaemia, Nausea, Confusional state, Hypertension, Vertigo, Head discomfort, Cognitive disorder, Fall, General physical health deterioration, Encephalopathy, Pelvic fracture, Fracture, Hypoacusis, Overdose, Restlessness, Dizziness, Drug interaction, Condition aggravated, Dehydration, Bedridden, Loss of personal independence in daily activities, Discomfort, Anxiety, Poor quality sleep, Contusion, Immobile, Mobility decreased, Medication error, Incorrect dose administered, Affect lability, Mood swings, Reduced facial expression, Foreign body, Sleep disorder, Prescription drug used without a prescription, |
||||
DONEPEZIL HYDROCHLORIDE, AMLODIPINE BESYLATE, PREGABALIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TELMISARTAN, RAMIPRIL, ROSUVASTATIN, APIXABAN, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, AMIODARONE HYDROCHLORIDE, AMLODIPINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ALPRAZOLAM, ROSUVASTATIN CALCIUM, FENTANYL, FENTANYL, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, FOLIC ACID, PREDNISONE, PREDNISONE, PREDNISONE, MELOXICAM, MELOXICAM, METOPROLOL TARTRATE, METOPROLOL, TELMISARTAN, TELMISARTAN, OXAZEPAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PREDNISONE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CAPTOPRIL, FENTANYL, GUAIFENESIN, MELOXICAM, MELOXICAM, METOPROLOL TARTRATE, METOPROLOL, PANTOPRAZOLE, PANTOPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 377 | 26487628 |
US |
58 | 2 |
Drug-induced liver injury, Drug interaction, |
||||
LISINOPRIL, SEMAGLUTIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 378 | 26487965 |
US |
49 | 1 |
Drug interaction, Oculogyric crisis, Tachycardia, Cogwheel rigidity, Muscle twitching, Dystonia, Drug effective for unapproved indication, |
||||
AMANTADINE HYDROCHLORIDE, SUGAMMADEX, LORAZEPAM, LORAZEPAM, DEXMEDETOMIDINE, DEXMEDETOMIDINE, |
||||
| 379 | 26488364 |
TR |
11 | 2 |
Chorea, Drug interaction, |
||||
PROPOFOL, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, FENTANYL, ROCURONIUM, ROCURONIUM BROMIDE, CEFAZOLIN SODIUM, CEFAZOLIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SUGAMMADEX, |
||||
| 380 | 26488823 |
EU |
88 | 1 |
Drug interaction, Neutropenia, Orchitis, |
||||
METHOTREXATE SODIUM, AMOXICILLIN, DAPAGLIFLOZIN, |
||||
| 381 | 26488850 |
EU |
77 | 1 |
Lactic acidosis, Drug level above therapeutic, Drug interaction, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FUROSEMIDE, FUROSEMIDE, |
||||
| 382 | 26489206 |
|||
Drug interaction, |
||||
TIRZEPATIDE, |
||||
| 383 | 26489823 |
27 | 1 | |
Drug interaction, Mania, Vision blurred, Feeling drunk, Muscle disorder, |
||||
ZOLPIDEM TARTRATE, PAROXETINE HYDROCHLORIDE, RISPERIDONE, |
||||
| 384 | 26490259 |
CN |
34 | 2 |
Pre-eclampsia, Drug interaction, Maternal exposure during pregnancy, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 385 | 26490408 |
US |
57 | 1 |
Abdominal pain upper, Vomiting, Gastrointestinal inflammation, Disorientation, Drug interaction, Tooth infection, |
||||
RISANKIZUMAB-RZAA, PREDNISONE, |
||||
| 386 | 26490843 |
EU |
86 | 1 |
Depressed level of consciousness, Drug interaction, |
||||
ERTAPENEM, ERTAPENEM SODIUM, FENTANYL, |
||||
| 387 | 26491184 |
US |
87 | 1 |
Pneumatosis intestinalis, Drug interaction, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, ABIRATERONE ACETATE, ABIRATERONE, INSULIN ASPART, GLIPIZIDE, GLIPIZIDE-TABLETS, PREDNISONE, |
||||
| 388 | 26491326 |
US |
||
Vitreous opacities, Visual impairment, Drug interaction, |
||||
PEGCETACOPLAN, PEGCETACOPLAN, FARICIMAB, FARICIMAB, |
||||
| 389 | 26491333 |
31 | 2 | |
Drug interaction, Bipolar disorder, Illness, Tremor, Hyperhidrosis, Insomnia, Nausea, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, QUETIAPINE, QUETIAPINE, |
||||
| 390 | 26481008 |
GB |
65 | 2 |
Hypertension, Drug interaction, |
||||
AMLODIPINE, LOSARTAN POTASSIUM, LOSARTAN, CARBAMAZEPINE, |
||||
| 391 | 26481082 |
EU |
50 | 1 |
Tardive dyskinesia, Withdrawal syndrome, Stereotypy, Parkinsonism, Drug interaction, Cognitive disorder, Chorea, Restlessness, Akathisia, Weight decreased, |
||||
POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, |
||||
| 392 | 26481123 |
EU |
12 | 2 |
Dizziness, Drug interaction, Hyperhidrosis, Agitation, Blood creatine phosphokinase increased, Mydriasis, Myoclonus, Extensor plantar response, Hyperreflexia, Dysarthria, Dystonia, Tremor, Muscle rigidity, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, HALOPERIDOL, HALOPERIDOL LACTATE, |
||||
| 393 | 26481355 |
CA |
1 | |
Drug interaction, Depression, |
||||
BUPROPION HYDROCHLORIDE, ATAZANAVIR SULFATE, ATAZANAVIR, CLONAZEPAM, EFAVIRENZ, LOPINAVIR AND RITONAVIR, LAMIVUDINE, LAMIVUDINE ORAL, QUETIAPINE FUMARATE, QUETIAPINE, SERTRALINE HYDROCHLORIDE, VALPROIC ACID, |
||||
| 394 | 26481426 |
US |
35 | 1 |
Hypokalaemia, Intentional product misuse, Drug interaction, |
||||
PREDNISONE, ACYCLOVIR, METOPROLOL TARTRATE, METOPROLOL, CLONIDINE, HYDRALAZINE HYDROCHLORIDE, IRBESARTAN, PANTOPRAZOLE, |
||||
| 395 | 26481464 |
US |
62 | 2 |
Methaemoglobinaemia, Drug interaction, |
||||
HYDROXYCHLOROQUINE SULFATE, DAPSONE GEL, 5%, DAPSONE, DASPONE, IVERMECTIN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, RIFAMPIN, |
||||
| 396 | 26481756 |
EU |
||
Drug interaction, Neuromuscular blockade, Therapeutic product effect incomplete, |
||||
DONEPEZIL HYDROCHLORIDE, ROCURONIUM BROMIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, MIRTAZAPINE, ROSUVASTATIN, DENOSUMAB, PROPOFOL, FENTANYL, OXYGEN, 0XYGEN, |
||||
| 397 | 26482118 |
EU |
80 | 2 |
Drug interaction, Pulmonary tuberculosis, Gastrointestinal haemorrhage, Anaemia, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RUXOLITINIB, RIFAMPIN, |
||||
| 398 | 26482125 |
EU |
72 | 2 |
Toxicity to various agents, Drug interaction, Serotonin syndrome, |
||||
SERTRALINE, QUETIAPINE, LINEZOLID, LINEZOLID, MEROPENEM, MEROPENEM, FLUCONAZOLE, FLUCONAZOLE, |
||||
| 399 | 26482830 |
US |
||
Drug ineffective for unapproved indication, Adverse drug reaction, Drug interaction, |
||||
COLESTIPOL HYDROCHLORIDE, |
||||
| 400 | 26482873 |
IN |
42 | 2 |
Bruxism, Drug-genetic interaction, Drug interaction, Product prescribing issue, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28
